International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: https://doi.org/10.5281/zenodo.13856416
Original Research Article
Modified Masood Scoring System’s Utility in Low Resource Setting for Diagnosis of Malignant Breast Lesion
Published
Sept. 29, 2024
Abstract

Background:Core needle biopsy is a gold standard for the diagnosis of breast lumps. Sometimes it is difficult for patients to afford its cost, especially in low- resource settings. Tissue processing is also not available at all hospitals and with all pathologists.We try to find out the concordance of MMSI (Modified Masood Scoring) in FNAC with histology and its utility in making better diagnoses thereby we can use it as a diagnostic procedure for malignant lesions in a low resource setting.Method: All patients with clinically palpable breast lumps referred to the Pathology department for fine - needle aspiration cytology (FNAC) were included. The patient was thoroughly informed and after taking consent, FNAC was done from 3 sites. These specimens’ lesions are also evaluated by applying Modified Masood’s Scoring Index (MMSI) and to access its usefulness in breast cytology also correlate with Histopathology.Results: The 89.52% and 98.15% of histological findings were correlated with MMSI category II and MMSI categories IV respectively. On applying the chi-square test, it is found to be highly significantly associated(p<0.001). Conclusion: MMSI gives a good prediction of the identification of breast lesions so one can plan effective management planning in low resource settings when the availability and affordability of core needle biopsy facility are not available.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
793 Views
83 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved